Scholars requires JavaScript. Please enable it in your browser to view this page.
Skip to main content
Scholars
Beta
Weill Cornell Medicine
Browse
About
Sign in
Loading co-authored publications…
Feedback
Scholars
/
Richard J. O'Reilly, MD
/
Co-authored with Zaki Molvi
Co-authored publications
Richard J. O'Reilly, MD and Zaki Molvi · 6 publications
CSV
Word
89
Zr-immunoPET-guided selection of a CD33xIL15 fusion protein optimized for antitumor immune cell activation and in vivo tumour retention in acute myeloid leukaemia.
European journal of nuclear medicine and molecular imaging
· 2024
RJ
Richard J. O'Reilly
ZM
Zaki Molvi
JS
Jason S. Lewis
PMID:
38987489
·
PMCID:
PMC11921880
·
DOI
·
Abstract
The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles.
Journal for immunotherapy of cancer
· 2023
RJ
Richard J. O'Reilly
ZM
Zaki Molvi
DA
David A. Scheinberg
PMID:
37775115
·
PMCID:
PMC10546156
·
DOI
·
9 citations
·
Abstract
The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles.
bioRxiv : the preprint server for biology
· 2023
RJ
Richard J. O'Reilly
ZM
Zaki Molvi
DA
David A. Scheinberg
PMID:
36798179
·
PMCID:
PMC9934604
·
DOI
·
16 citations
·
Abstract
Cytomegalovirus-specific T cells following haploidentical transplants: reshaping a repertoire by half.
Haematologica
· 2023
RJ
Richard J. O'Reilly
ZM
Zaki Molvi
PMID:
36453111
·
PMCID:
PMC10230411
·
DOI
Allogeneic Tumor Antigen-Specific T Cells for Broadly Applicable Adoptive Cell Therapy of Cancer.
Cancer treatment and research
· 2022
RJ
Richard J. O'Reilly
ZM
Zaki Molvi
PMID:
35551658
·
DOI
·
2 citations
·
Abstract
A TCR mimic monoclonal antibody reactive with the "public" phospho-neoantigen pIRS2/HLA-A*02:01 complex.
JCI insight
· 2022
RJ
Richard J. O'Reilly
ZM
Zaki Molvi
IL
Ivo Lorenz
DA
David A. Scheinberg
PMID:
35260532
·
PMCID:
PMC8983142
·
DOI
·
21 citations
·
Abstract